Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study.

Publication

Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study.

Journal Paper/Review - Jul 1, 2023

Filippidis Paraskevas, Damas José, Viala Benjamin, Assal Frédéric, Tshikung Olivier Nawej, Tarr Philip X00a0 E, Derfuss Tobias, Oberholzer Michael, Jelcic Ilijas, Hundsberger Thomas, Sacco Leonardo, Cavassini Matthias, Du Pasquier Renaud A, Darling Katharine Elizabeth Anna, NAMACO Study Group, Swiss HIV Cohort Study

Citation

Filippidis P, Damas J, Viala B, Assal F, Tshikung O, Tarr P, Derfuss T, Oberholzer M, Jelcic I, Hundsberger T, Sacco L, Cavassini M, Du Pasquier R, Darling K, NAMACO Study Group, Swiss HIV Cohort Study. Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study. J Acquir Immune Defic Syndr 2023; 93:219-228.

Type

Journal Paper/Review (English)

Journal

J Acquir Immune Defic Syndr 2023; 93

Publication Date

Jul 1, 2023

Issn Electronic

1944-7884

Pages

219-228

Brief description/objective

Despite modern antiretroviral therapy, human immunodeficiency virus-1 (HIV-1) ribonucleic acid (RNA) escape into the cerebrospinal fluid (CSF) may occur. We examined the prevalence of and factors associated with CSF HIV-1 escape among people living with HIV (PLWH) in Switzerland.